Clinical Trial

Adjuvant Chemoradiotherapy Versus Chemotherapy for Pancreatic Cancer (ADJUPANC)

Name: Adjuvant Chemoradiotherapy Versus Chemotherapy for Pancreatic Cancer (ADJUPANC) — clinical trial record (NCT06427447)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ADJUPANC

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

In this trial, we aim to compare the outcomes of adjuvant chemoradiotherapy with chemotherapy for patients with resected pancreatic cancer who are at high risk of disease progressions.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2024-05-19.

Trial Details

NCT Number	NCT06427447
Lead Sponsor	Changhai Hospital
Conditions	Pancreatic Cancer
Enrollment	770 participants
Start Date	2024-08-06
Primary Completion	2028-06-30 (estimated)
Study Completion	2029-06-30 (estimated)
Updated on ClinicalTrials.gov	2025-02-04